In the last decade several synaptonuclear protein messengers including Jacob, CRTC1, AIDA-1, ProSaP2/Shank3 and RNF10 have been identified and characterized as key players for modulation of synaptic transmission and synaptic plasticity. Activation of excitatory glutamatergic synapses leads to their shuttling from the synapse to the nucleus, mostly importin-mediated, and subsequent regulation of gene transcription needed for long lasting modifications of synaptic function. Accordingly, increasing evidences show that alterations of the activity of synaptonuclear messengers are correlated to synaptic failure as observed in different synaptopathies. Specifically, recent studies demonstrate that the modulation of the activity of synaptonuclear messengers could represent a novel molecular target in the pathogenesis of both neurodevelopmental disorders and neurodegenerative diseases such as Alzheimer's disease.

Synapse-to-nucleus communication: from developmental disorders to Alzheimer's disease / E. Marcello, M. Di Luca, F. Gardoni. - In: CURRENT OPINION IN NEUROBIOLOGY. - ISSN 0959-4388. - 48(2018 Feb), pp. 160-166. [10.1016/j.conb.2017.12.017]

Synapse-to-nucleus communication: from developmental disorders to Alzheimer's disease

E. Marcello;M. Di Luca;F. Gardoni
2018

Abstract

In the last decade several synaptonuclear protein messengers including Jacob, CRTC1, AIDA-1, ProSaP2/Shank3 and RNF10 have been identified and characterized as key players for modulation of synaptic transmission and synaptic plasticity. Activation of excitatory glutamatergic synapses leads to their shuttling from the synapse to the nucleus, mostly importin-mediated, and subsequent regulation of gene transcription needed for long lasting modifications of synaptic function. Accordingly, increasing evidences show that alterations of the activity of synaptonuclear messengers are correlated to synaptic failure as observed in different synaptopathies. Specifically, recent studies demonstrate that the modulation of the activity of synaptonuclear messengers could represent a novel molecular target in the pathogenesis of both neurodevelopmental disorders and neurodegenerative diseases such as Alzheimer's disease.
Neuroscience (all)
Settore BIO/14 - Farmacologia
   Synapse-to-nucleus communication in Alzheimer's disease
   STAD
   MINISTERO DELL'ISTRUZIONE E DEL MERITO

   Meccanismi di patogenesi negli stadi precoci della malattia di Alzheimer: identificazione di target armacologici e biomarkers
   MINISTERO DELL'ISTRUZIONE E DEL MERITO
   2015N4FKJ4_001
feb-2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0959438817301629-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 312.08 kB
Formato Adobe PDF
312.08 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/548134
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 30
social impact